Editor is responsible to communicate with author for a particular assigned manuscript. He/She has the rights to accept or reject the manuscript during preliminary screening. Editor can reject the manuscript if the content is not related to pharmacovigilance activities. The manuscript could be further processed only if it passes plagiarism check and the maximum similarity allowed is 10 %.
After obtaining the review comments editor can take decision by own or discuss with editorial board members, whether to accept or reject or acceptable with minor/major revisions. Editor should maintain confidentiality.
Editor- in- chief should communicate the decision to the author for final approval of the manuscript.